States

Weekly reads: odd FDA PRP warning, H3.3 & CTCF, Iowa AG gets $2.5M on stem cell clinic, Colossal Biosciences

PRP-Platelet-Rich-Plasma-injected-into-a-hand-1024x576-1

Platelet-rich plasma or PRP is a regenerative product that has grown in popularity. The literature on clinical applications of PRP is all over the place. Whether it works or not for any particular application is unclear to me. Many orthopedists seem enthused about it. I haven’t seen any major adverse events linked to PRP. PRP […]

Weekly reads: odd FDA PRP warning, H3.3 & CTCF, Iowa AG gets $2.5M on stem cell clinic, Colossal Biosciences Read More »

Wyoming stem cell bill is latest risky, anti-FDA state legislation

Eric Barlow, Wyoming stem cell bill

There’s a new Wyoming stem cell bill that poses risks to the public. The so-called Stem Cell Freedom Act would allow clinical use of non-FDA-approved cells in that state. With this, Wyoming joins other states such as Florida that are pushing back on the FDA. The new Florida stem cell law is likely already causing

Wyoming stem cell bill is latest risky, anti-FDA state legislation Read More »

Iowa AG wins $1M from stem cell clinic

Travis Autor, Travis Broughton

State attorneys general have done a good job addressing the stem cell clinic problem locally. They’ve increasingly taken action on unproven stem cells and related firms. In some ways, they’ve been more effective than the feds. The AG successes  have been particularly important given the uneven activity from the FDA and FTC. Iowa AG wins

Iowa AG wins $1M from stem cell clinic Read More »

Pivot of Nasdaq-traded Celularity highlights tensions & risks from Florida stem cell law

celularity

Robert Hariri has been a familiar face in the biotech field, including as CEO of Celgene, but one of his newer companies, Celularity, has been in the news lately. He also co-founded a firm called Fountain Life that has recently partnered with Celularity. I’ve been following these firms for years and was struck by a

Pivot of Nasdaq-traded Celularity highlights tensions & risks from Florida stem cell law Read More »

Florida stem cell bill is part of state trend to sidestep FDA

Jay Trumbull, Florida stem cell bill

A new Florida stem cell bill directly challenges the FDA and its CBER branch. If passed, which seems relatively likely, the Florida bill would become of state trend.  A Utah stem cell law and a broader Nevada biologics law legally okay non-FDA approved biologics. These and other pending state efforts pose major risks to FDA

Florida stem cell bill is part of state trend to sidestep FDA Read More »

Arkansas adds to wave of state AG actions vs. stem cell clinics

Sarah-Knife-Chief-M.D.-chiropractor-Serge-Francois-D.C.-From-KNWA-small

It’s encouraging to see that the states including now Arkansas via their attorney generals (or is it attorneys general?) are taking more action against stem cell clinic firms, but the big scope of AG action has somewhat surprised me. Arkansas AG suit The latest AG action on a stem cell clinic type firm comes from

Arkansas adds to wave of state AG actions vs. stem cell clinics Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.